One of the recommendations from the previous episode (TGN1412) was that in the first trial on humans, the administrations should be staggered so that if there i

One of the recommendations from the previous episode (TGN1412) was that in the first trial on humans, the administrations should be staggered so that if there is an unexpected adverse reaction, you only get one or two patients down. It sounds like that may not have been taken on board.